Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital
NCT06750744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-12-27
Summary
The goal of this clinical trial is to identify the predictors of antibiotic resistance whether clinical or laboratory or radiological or all
Conditions
- Identify the Predictors of Antibiotic Resistance
Interventions
- RADIATION
-
chest x ray
chest X ray identify severity of pneumonia
- RADIATION
-
chest X ray
chest radiological evaluation via x ray
- DRUG
-
Tigecycline (Tygacil)
selective antibiogram
Sponsors & Collaborators
-
Mohamed Sabry
lead OTHER
Principal Investigators
-
mohamed sabry eltarhony, lecturer · Alexandria University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-01
- Primary Completion
- 2024-12-11
- Completion
- 2024-12-12
- FDA Drug
- Yes
- FDA Device
- Yes
Countries
- Egypt
Study Locations
More Related Trials
-
A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
NCT05306223 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections
NCT06990126 ·Status: ENROLLING_BY_INVITATION
-
Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics
NCT01311349 ·Status: COMPLETED
-
Antimicrobial Resistance (AMR) Study
NCT06944158 ·Status: RECRUITING
-
6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province
NCT07198685 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis
NCT07129629 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Detection of Efflux Pump Genes Mediating Ciprofloxacin Resistance in Staphylococcus Aureus Isolates in Sohag University Hospitals
NCT05828550 ·Status: COMPLETED ·Phase: NA
-
Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19
NCT04350931 ·Status: UNKNOWN ·Phase: PHASE3
-
Eravacycline Combination Therapy for MRAB
NCT06282835 ·Status: RECRUITING
-
TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
NCT00449644 ·Status: COMPLETED ·Phase: PHASE2
-
Arginine as an Adjuvant Treatment Against Tuberculosis
NCT00857402 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB
NCT02333799 ·Status: COMPLETED ·Phase: PHASE3
-
PK/PD of Ertapenem In Patients With TB
NCT01730664 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
NCT07213765 ·Status: RECRUITING ·Phase: PHASE4
-
The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.
NCT04546815 ·Status: UNKNOWN
-
Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
NCT01498419 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
The Study of Bacteriology and Pathogen Drug Sensitivity of Chronic Dacryocystitis
NCT03216642 ·Status: UNKNOWN
-
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
NCT03338621 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
NCT04537663 ·Status: COMPLETED ·Phase: PHASE4
-
Shortening Treatment by Advancing Novel Drugs
NCT02342886 ·Status: COMPLETED ·Phase: PHASE3
-
MDR Bacilli Surveillance and Clinical Feature in China
NCT02140853 ·Status: UNKNOWN
-
Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.
NCT00205816 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
NCT01671358 ·Status: COMPLETED
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED